GLPwatch
[Cardiac effects of glucagon-like peptide 1].
Ugeskr Laeger · 2010
Last updated 2026-05-28| Journal | Ugeskr Laeger, 2010 |
|---|---|
| Citations | 0 |
| Relative citation ratio | 0.00 |
| NIH percentile | 0 |
| Molecules | — |
| Conditions studied | Cardiovascular Risk Reduction, Heart Failure |
Full record and abstract on PubMed 20961500 ↗